
GRAIL, erken kanser tespitine odaklanan bir sağlık teknolojileri şirketidir. Şirket, kanser mortalitesinin seyrini değiştirmek amacıyla çoklu kanser erken tespitine (multi-cancer early detection, MCED) yönelik kan temelli tarama yaklaşımları geliştirir. Bu amaçla yeni nesil dizileme, geniş ölçekli klinik çalışmalar ve bilgisayar-bilimi ile veri biliminin birleşiminden yararlanır.GRAIL’in faaliyetleri, semptomlar ortaya çıkmadan önce pek çok ölümcül kanser türünde dolaşımdaki hücresiz DNA’nın met
TR
Ömer Said Aydın

Grail is a health technology company focused on early cancer detection. Its mission is to transform cancer mortality through the development of multi-cancer early detection (MCED) blood tests. To achieve this, Grail integrates next-generation sequencing (NGS), large-scale clinical studies, and advances in computer and data science.The company’s approach is based on detecting cancer signals by analyzing methylation patterns in circulating cell-free DNA (cfDNA), enabling the identification of mult
EN
Ömer Said Aydın

GRAIL is a health technology company focused on early cancer detection. The company develops blood-based screening approaches for multi-cancer early detection (MCED) with the aim of altering the course of cancer mortality. To this end, it leverages next-generation sequencing large-scale clinical studies and the integration of computer science and data science.GRAIL’s activities are based on detecting cancer signals by deciphering methylation signatures of cell-free DNA in the bloodstream before
EN
Ömer Said Aydın